M&A Deal Summary |
|
|---|---|
| Date | 2021-11-11 |
| Target | Forendo Pharma |
| Sector | Life Science |
| Buyer(s) | Organon |
| Deal Type | Add-on Acquisition |
| Deal Value | 75M USD |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Healthcare Services |
| Revenue | 6.4B USD (2024) |
Organon develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health. Organon was founded in 1923 and is based in Jersey City, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 3 |
| Country: Finland M&A | 1 of 1 |
| Year: 2021 M&A | 2 of 2 |
| Size (of disclosed) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-16 |
Alydia Health
Menlo Park, California, United States Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding. It develops Jada System, a medical device for abnormal postpartum uterine bleeding and postpartum hemorrhage (PPH), the number one cause of maternal death. The company's single-minded focus is to radically improve the treatment path for postpartum hemorrhage from the traumatic, life-altering condition that it is today. Alydia Health was formed in 2011 and is based in Menlo Park, California. |
Buy | $240M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-09-18 |
Dermavant Sciences
Long Beach, California, United States Dermavant Sciences is focused on developing and commercializing innovative therapeutics in immuno-dermatology. Dermavant Science’s medical dermatology pipeline includes earlier-development, late-stage, and commercialized, product candidates that target specific unmet needs in growing immuno-dermatology markets, plaque psoriasis and atopic dermatitis, as well as other immunological and inflammatory diseases. Dermavant Sciences was founded in 2015 and is based in Long Beach, California. |
Buy | $1.2B |
